Regarding the active treatment groups, although both have been decreasing recently, patients with higher oncological risk (high ISUP GG, high PPC, or high PSA) more actively tended to decide on active treatment, which is consistent with previous data showing an increasing trend of RP in the intermediate-to-high-risk group 17 .
← all excerpts
Explainable ML models for a deeper insight on treatment decision for localized prostate cancer.
1
—
—